Effect of initial high-efficacy disease modifying therapy in relapsing-remitting multiple sclerosis: a nationwide cohort study

Mathias Due Buron, Thor Ameri Chalmer, I Barzinji, J R Christensen, M K B Christensen, V Hansen, Zsolt Illés, Henrik Boye Jensen, Matthias Kant, T. Petersen m.fl.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdato12. sep. 2019
StatusUdgivet - 12. sep. 2019
BegivenhedECTRIMS 2019: 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis - Stockholm, Sverige
Varighed: 11. sep. 201913. sep. 2019
Konferencens nummer: 35
https://www.ectrims-congress.eu/2019.html

Konference

KonferenceECTRIMS 2019
Nummer35
LandSverige
ByStockholm
Periode11/09/201913/09/2019
Internetadresse

Citationsformater

Buron, M. D., Chalmer, T. A., Barzinji, I., Christensen, J. R., Christensen, M. K. B., Hansen, V., Illés, Z., Jensen, H. B., Kant, M., & Petersen m.fl., T. (2019). Effect of initial high-efficacy disease modifying therapy in relapsing-remitting multiple sclerosis: a nationwide cohort study. Poster session præsenteret på ECTRIMS 2019, Stockholm, Sverige.